Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT01834170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
ClinicalTrials.gov study NCT02350686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
ClinicalTrials.gov study NCT00057928. IPD Sharing: Not stated. Countries: 2. Publications: 0.
FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX
ClinicalTrials.gov study NCT04167007. IPD Sharing: NO. Countries: 1. Publications: 0.
EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT00377936. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT06498518. IPD Sharing: YES. Countries: 1. Publications: 0.
Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00003928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)
ClinicalTrials.gov study NCT05431244. IPD Sharing: NO. Countries: 1. Publications: 0.
Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.
ClinicalTrials.gov study NCT00159471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
ClinicalTrials.gov study NCT00490659. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT00055250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT02188693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copanlisib and Gemcitabine in Relapsed/Refractory PTCL
ClinicalTrials.gov study NCT03052933. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
ClinicalTrials.gov study NCT03093909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00251355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer
ClinicalTrials.gov study NCT02101580. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00039403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT06423326. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective
ClinicalTrials.gov study NCT03110484. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00021346. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.